1. Steinberg MH. Sickle cell disease: manifestations of thalassemia and hemoglobinopathies. Hematology Am Soc Hematol Educ Program. 2019;2019(1):567-574.
[2]
2. Adekile A, Tuli M, Haider M, et al. Osteonecrosis in sickle cell disease. Pediatr Blood Cancer. 2021;68(Suppl 5):e29154.
[3]
3. Mukisi-Mukaza M, Elbaz A, Samuel-Leborgne Y, et al. Prevalence, clinical features and risk factors of osteonecrosis in sickle cell disease. Orthop Traumatol Surg Res. 2020;106(2):315-320.
[4]
4. Hernigou P, Daltro G, Filippini P, et al. Osteonecrosis repair with bone marrow cell therapies: state of the clinical art. Bone Joint Res. 2022;11(2):81-93.
[5]
5. Poillon GJ, Kim HC, Rosse WF. Orthopedic complications of sickle cell disease. Orthop Clin North Am. 2021;52(3):321-334.
[6]
6. Vichinsky EP, Neumayr LD, Gold JI, et al. Pain and sickle cell disease: a systematic review. Blood Adv. 2020;4(18):4498-4510.
[7]
7. Mahendra A, Sheth S, Vichinsky E. Musculoskeletal complications of sickle cell disease. Rheum Dis Clin North Am. 2022;48(2):417-434.
[8]
8. Ganguli A, Mukherjee D, Ranjan P. Osteonecrosis in thalassemia: a review. Hemoglobin. 2021;45(2):71-78.